5084.0 Comparative Effectiveness Research in Public Health

Wednesday, November 2, 2011: 8:30 AM
In clinical settings comparative effectiveness research (CER) compares the effectiveness of two or more treatments for a certain medical condition for a particular set of patients. CER also is implemented in public health to compare the effectiveness of two or more prevention or health promotion interventions to determine which interventions yield the most benefit in which populations. A new role for CER is being carved out in public health. The effectiveness of particular interventions may depend on the settings in which they are applied (e.g., minority communities, tribal clinics), and CER can help identify the characteristics essential to success in specific communities and settings. The focus can also be on dissemination of public health interventions, policy changes, or environmental changes that promote healthy behaviors or reduce behaviors that increase risk of disease or disability. The long-term goal is to translate the most effective public health interventions or strategies into public health programs, practice, and policy in communities throughout the country in a time- and cost-efficient manner. Public health CER to prevent chronic diseases and promote health can contribute to reducing health disparities, increasing scientific knowledge, and reducing health care costs. As the nation moves to reduce health care costs and institute evidence-based, cost-effective public health programs, knowing which of several interventions or strategies are best in preventing disease and disability and promoting health is essential.
Session Objectives: 1. Discuss how comparative effectiveness research is being utilized in public health.
Danielle Ross, PhD, MSc, MA

8:30 AM
Comparative effectiveness research in public health: Background and overview
Danielle Ross, PhD, MSc, MA, Nancy Lee, MD, Diane Green, PhD, MPH and Eduardo J. Simoes, MD, MSc, MPH
9:00 AM
Comparative effectiveness of telemedicine to detect diabetic retinopathy in American Indians and Alaska Natives
Steven Mansberger, MD, MPH, Kenneth Gleitsmann, MD, Stuart Gardiner, MA, CASM, PhD, Christina Sheppler, PhD and Thomas Becker, MD, PhD
9:15 AM
9:30 AM
A combined lifestyle and medication intervention to reduce CVD risk
Thomas C. Keyserling, MD, MPH, Stacey Sheridan, MD, MPH and Lindy Draeger, MPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Public Health Education and Health Promotion
Endorsed by: American Indian, Alaska Native and Native Hawaiian Caucus

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)